Santos Luiz E C, Rodrigues Antônio M, Lopes Mariana R, Costa Victor D C, Scorza Carla A, Scorza Fulvio A, Cavalheiro Esper A, Almeida Antônio-Carlos G
Laboratório de Neurociência Experimental e Computacional, Departamento de Engenharia de Biossistemas, UFSJ, Brazil.
Disciplina de Neurologia Experimental, Escola Paulista de Medicina, Unifesp, Brazil.
Neuroscience. 2017 Jan 6;340:530-541. doi: 10.1016/j.neuroscience.2016.11.015. Epub 2016 Nov 18.
Nonsynaptic mechanism changes, particularly the enhancement of NKCC1 expression in the dentate gyrus (DG) after 4weeks of ethanol consumption, motivate the present work, in which rats were submitted to a period of chronic consumption (12weeks). Four groups of six animals (6-week-old male Wistar rats) were formed, including the control (C), ethanol 1 (E1), ethanol 2 (E2) and ethanol 3 (E3) groups. The rats in the E1, E2 and E3 groups were treated daily with a 30% v/v solution of ethanol, administered via oral gavage (1.0, 2.0 and 3.0g/kg, respectively). Nonsynaptic epileptiform activities (NEA) were induced by means of the zero-Ca and high-K model using hippocampal slices and were recorded in the DG. The presence of NKCC1, KCC2, α-Na/K-ATPase and GFAP immunoreactivity was analyzed. The results demonstrate that alcohol consumption changes NEA, and these changes are more prominent at the lower dosage. An increase in the DC shifts associated with epileptiform discharges was present with the low dose. This increase was correlated with the increment of NKCC1 expression. Confocal microscopy images indicate the NKCC1 increase was pronounced in the initial axonal segment of granule cells. The blockage of these cotransporters during NEA induction with bumetanide suppressed the DC shift increase and diminished all parameters of NEA that were quantified for all groups treated with ethanol. Therefore, the increase in NKCC1 expression and the effective activity of this cotransporter, which were observed in the treated groups, suggest that drugs that act for block NKCC1 represent promising strategies for diminishing the effects of alcohol damage on the brain.
非突触机制的变化,尤其是在乙醇摄入4周后齿状回(DG)中NKCC1表达的增强,推动了本研究工作,其中大鼠经历了一段慢性摄入期(12周)。将六只动物(6周龄雄性Wistar大鼠)分为四组,包括对照组(C)、乙醇1组(E1)、乙醇2组(E2)和乙醇3组(E3)。E1、E2和E3组的大鼠每天经口灌胃给予30% v/v乙醇溶液(分别为1.0、2.0和3.0 g/kg)。使用海马切片通过零钙和高钾模型诱导非突触性癫痫样活动(NEA),并在DG中进行记录。分析了NKCC1、KCC2、α-Na/K-ATP酶和GFAP免疫反应性的存在情况。结果表明,饮酒会改变NEA,且这些变化在较低剂量时更为显著。低剂量时存在与癫痫样放电相关的直流偏移增加。这种增加与NKCC1表达的增加相关。共聚焦显微镜图像表明,NKCC1在颗粒细胞的初始轴突段增加明显。在用布美他尼诱导NEA期间阻断这些协同转运蛋白可抑制直流偏移增加,并减少了所有乙醇处理组量化的NEA的所有参数。因此,在处理组中观察到的NKCC1表达增加和该协同转运蛋白的有效活性表明,作用于阻断NKCC1的药物代表了减轻酒精对大脑损害影响的有前景的策略。